Author: Conference
ISBN 978-1-84735-629-1 

Published: 2011
9th International Conference on the Registration, Evaluation, and Authorisation of Chemicals and its Impact on US Trade
30 November 2010 marked the deadline for chemical producers and importers to register all high volume and potentially toxic substances. Chemicals that have not been registered with the requisite safety information by this date are to be withdrawn from the market under the "no data, no market" ruling, giving the potential to cause untold chaos in chemical supply chains. Indeed, successes and failures from this first set of REACH registrations in 2010 are expected to impact the use of products on the EU market and beyond, as well as influence chemical legislation initiatives across the globe. In particular, industry and regulators will become engaged with Evaluation during 2011, where data submitted in registration dossiers are reviewed and potentially challenged.

In 2011 customers in the EU will begin facing the knock-on requirements of registrations from 2010, changes in classification under the EU implementation of the Globally Harmonised System (GHS), conditions imposed by Exposure Scenarios and even 'uses advised against'. Not only are there widespread concerns over the EU's implementation of the GHS for the classification, labelling, and packaging of substances (CLP), but 2011 also brings new obligations, such as the need to notify substances of very high concern (SVHC) to the European Chemicals Agency (ECHA). In the US plans to introduce the GHS will undoubtedly cause similar fears.

At the same time, the next registration deadline is only 2 ½ years away. This second phase of Registration presents additional management hurdles, as it involves a large number of substances that may be relatively 'data poor' compared with substances registered in 2010. Companies must already begin planning, in particular with regards to budgeting for this next step in REACH.

2011, therefore, presents industry and regulators with a critical year for gaining experience with how REACH actually works in practice. In turn, changes in official guidance and a legislative review in 2012 offer the possibility of improvements to the workability of REACH.

Whether you're a cosmetics company, an aerospace manufacturer or a raw material supplier, REACH applies to you. These proceedings cover all the presentations from the conference which enveloped some of the vital lessons that have been learned, how the next deadlines in 2013 will affect the way you do business and what damage limitation controls can be put in place for 2011 when many fail to meet their obligations.




Session 1: REACH – Experiences & Updates 

Paper 1 Keynote Presentation REACH update and progress on registration 

Eva Sandberg, European Chemicals Agency (ECHA), Finland 


Paper 2 Managing dossiers – deadlines and updates 

Dr. Steffen Erler, Smithers Viscient, UK 


Paper 3 Lessons learned from REACH implementation and thoughts for going forward to 2013 

Thomas G Grumbles, Cardno ENTRIX, USA 


Session 2: Technical Complexities 

Paper 4 Navigating REACH from a small business perspective 

April A Cesaretti, The HallStar Company, USA 


Paper 5 Use of science in REACH regulatory affairs 

Dr. Robbie Waites, SABIC Innovative Plastics, USA 


Paper 6 Consortium Management – How will best practice evolve in the period to 2013 

Paul Ashford, Caleb Management Services Ltd, UK 


Session 3: Tools & Methods 

Paper 7  Legal interpretations and challenges Ruxandra Cana, Field Fisher Waterhouse LLP, Belgium  PAPER UNAVAILABLE  


Paper 8  Sens-it-iv: in vitro methods for sensitisation Erwin Roggen, Novozymes AS, Denmark  


Paper 9 Exposure in the supply chain: from development to implementation 

Tine Vandenbrouck & Elke Van Asbroeck, Apeiron-Team NV, Belgium 


Paper 10 The extended safety datasheet – challenges and opportunities 

Dr. Mark Pemberton, Lucite International UK Ltd, UK 


Session 4: Safe Use, Restriction, and Authorisation 

Paper 11 From use descriptors to safe use - one more step in the REACH journey 

Barry Clayton, Reichhold Inc, USA 


Paper 12 SVHC duties as we move towards notification and authorisation 

Eva Sandberg, European Chemicals Agency (ECHA), Finland 


Paper 13 SIN list, restriction & authorisation 

Jerker Ligthart  &, Nardono Nimpuno International Chemical Secretariat, Sweden 


Session 5: Managing SVHCs 

Paper 14 SVHCs in articles 

Dave Bender, Tyco Electronics, USA 


Paper 15 Managing substances of very high concern in the retail sector 

Simon Brearley, The REACH Centre Ltd, UK 


Paper 16 Impact of REACH and CLP for manufacturers of articles 

Barry Podd, Kimberly-Clark Europe, UK 


Session 6: Chemicals Policy 

Paper 17 EU chemicals policy – beyond REACH 

Mamta Patel, Chemical Watch, UK 


Paper 18 TSCA reform: Learning hard lessons from REACH experience 

Dr. Herb Estreicher, Keller & Heckman LLP, USA 


Paper 19 REACH and the interplay of state and federal chemicals policy in the US: Lessons Learned 

Prof Joel A Tickner, University of Massachusetts Lowell, USA 


Session 7: GHS and CLP 

Paper 20 CLP: The harmonisation process and the C&L inventory 

Eva Sandberg, European Chemicals Agency (ECHA), Finland 


Paper 21 US OSHA implementation of the GHS 

Jennifer Silk, Retired from OSHA, currently Consultant & UNITAR Training Advisor on GHS, USA 


Paper 22 Managing CLP compliance: the essentials for business 

Simon Brearley, The REACH Centre Ltd, UK